esorubicin has been researched along with Cancer of the Uterus in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alberts, DS; Green, JB; Green, S; Nahhas, WA; O'Toole, RV; Wallace, DL | 1 |
1 trial(s) available for esorubicin and Cancer of the Uterus
| Article | Year |
|---|---|
Esorubicin in advanced endometrial cancer: an ineffective and potentially toxic therapy. A Southwest Oncology Group study.
Topics: Antibiotics, Antineoplastic; Doxorubicin; Drug Evaluation; Female; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Risk Factors; Survival Rate; Uterine Neoplasms | 1991 |